A study of consent for participation in a non-therapeutic study in the pediatric intensive care population

Kusum Menon1, Roxanne Ward,

  • 1Department of PICU, CHEO, , Ottawa, Ontario, Canada.

Journal of Medical Ethics
|January 25, 2013
PubMed

Insights

Legal guardians faced barriers like unavailability and feeling overwhelmed when consenting to paediatric critical care research. Addressing these issues is crucial for future study validity and generalizability.

Area of Science:

  • Critical care medicine
  • Pediatric research ethics
  • Informed consent processes

Background:

  • Obtaining informed consent for pediatric critical care research presents unique challenges.
  • Understanding guardian-related barriers is essential for improving participation rates.

Purpose of the Study:

  • To identify legal guardian-related barriers to consent procurement in a pediatric critical care research study.
  • To document the reasons provided by guardians for non-participation.

Main Methods:

  • A multicenter, prospective cohort study involving 1707 eligible patients.
  • Data collected on consent encounters, guardian availability, language barriers, and reasons for refusal.

Main Results:

  • Key barriers included guardian unavailability (321/1707) and language issues (84/1707).
  • The overall consent rate was 42% among 917 approached guardians.
  • Common reasons for refusal included feeling overwhelmed (117/429) and not wanting additional interventions (63/429).

Conclusions:

  • Consent procurement in pediatric critical care research is hindered by multiple factors, notably guardian availability and feeling overwhelmed.
  • Further research is needed to assess the impact on study validity and develop effective consent models.
Abstract

Related Concept Videos

Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Nurses' Legal Responsibilities I01:27

Nurses' Legal Responsibilities I

In healthcare, informed consent is a crucial process that involves thoroughly communicating medical treatment options to patients, including benefits, risks, potential side effects, and alternatives. This process enables patients to make well-informed decisions about their care, ensuring they understand the implications of their choices before consenting to or refusing treatment.
The legal responsibilities of a nurse regarding informed consent include the following:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...